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The thymus is known to play a key role in self vs . non-self recognition (1) . For
example, thymic grafts have been shown to induce tissue transplantation tolerance
in allogeneic models in both mice and birds (2-4). The thymus is also the site of
tolerance induction to self MHC (5), but whether tolerance to autologous protein
antigens originates in the thymus is unknown. Analysis of self tolerance has been
hampered not only by the lack of suitable experimental systems, but also by the
presence of autoantigens, which renders the detection of either cellular or humoral
immunity difficult. We have examined the role of the thymus in natural tolerance
to a physiologic protein antigen (the fifth component of mouse complement, C5)
by taking advantage of two congenic strains of mice that differ only in the presence
or absence of C5 . Our experiments indicate that C5-deficient (C5 - ) mice grafted
with thymus from C5-sufficient (C5+) mice failed to make humoral antibody to C5,
suggesting that the transfer of thymus had induced tolerance. To further establish
that tolerance was acquired in the thymus, we were able to adoptively transfer the
state of tolerance by lymphoid cells from the C5 - mice grafted with C5+ thymus
into irradiated C5- hosts. These results in mice with identical MHC appear to be
the first to demonstrate that natural tolerance to self-protein antigen is "learned"
in the thymus. This observation may have both fundamental and clinical significance.
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Materials and Methods
BriefDefinitive Report
Animals.
￿
Male 6-8-wk old B10.D2 OSN/J, B10.D2 NSN/J, and A/J, and newborn (1-3-d-
old) B10.D2 OSN/J and B10.D2 NSN/J mice were obtained from The Jackson Laboratory,
Bar Harbor, ME, and maintainedat The Center for BloodResearch animal facilities. Animals
to be irradiated were prepared as previously described (6).
Antigens.
￿
Murine C5 for immunization was prepared from the acid euglobulin fraction
of B10.D2 NSN serum as previously described (6) at a dose of 50 ug per mouse in CFA (Difco
Laboratories Inc., Detroit, MI), intraperitoneally. OVA (Sigma Chemical Co., St. Louis, MO)
dose was also 50 wg per mouse in CFA, intraperitoneally.
Thymectomy andNeonatal Thymic Grafting
￿
Adult mice were thymectomized using standard
surgical techniques. Neonatal mice were killed by ether anesthesia and their thymic lobes
were grafted subcutaneously under the left axillae of recipient mice. Thymectomy and en-
graftment were confirmed histologically.
Radiation Transfer Protocols.
￿
B10.D2 mice were lethally irradiated with 780 rad in a divided
dose as previously described (6).
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Cell Preparationsfor Transfers.
￿
Bone marrow was obtained from B10.D2 OSN mice, treated
with antiThy-1.2 and guinea pig complement and 10' cells injected intravenously into ir-
radiated recipient mice . Nonadherent (NA) spleen cell suspensions were prepared as previ-
ously described (6) and 7 x 10' cells were injected intravenously into recipients .
Assay ofMouse C5 andAnti-mouse C5 .
￿
These assays were done as previously described (6) .
Assay ofMouse Anti-OVA .
￿
Anti-OVA antibody response was measured by ELISA at asera
dilution of 1 :1,000 .
StatisticalAnalysis .
￿
ForC5 inhibition levels, C5 levels, and anti-OVA responses, arithmetic
means andSDs were calculated . Individual positive responseswere determined as those values
abovethe mean plus two SDs of the control group . Groups were compared by student's t test .
Results
Adult C5 - (B10.D20SN) hosts were thymectomized, grafted with neonatal thy-
mus from either C5 - or C5' (B10.D2NSN) donors, irradiated, and reconstituted
with antiThy-1.2 + C-treated bone marrow from C5 - donors . In both groups the
serum C5 level measured by a hemolytic assay was nondetectable . In preliminary
experiments, C5- mice grafted with neonatal C5+ thymus and immunized with C5
in CFA 3 wk after reconstitution showed an initial weak antibody response to the
primary (1°) immunization that diminished after secondary (2°) and tertiary an-
tigen challenge as assayed by inhibition of C5-dependent hemolysis . In a second
experiment, C5- mice grafted with C5+ thymus were challenged with C5/CFA 2
mo after reconstitution and their antibody response was measured (Fig . 1) . Before
immunization, serum C5 levels were undetectable in C5- mice with either C5 - or
C5+ grafts (data not shown) . Control C5 - mice grafted with autologous thymus
responded in the 1° response, although slightly less than intact C5- controls ; in the
2° response, both of these groups responded equally well . In contrast, C5 - mice
grafted with C5' thymus failed to respond both in the 1° and 2° response . The
results suggest that the thymus grafts from C5+ mice induced tolerance to C5 in
the C5 - hosts .
FIGURE 1 .
￿
Effect o£ neonatal C5 - thy-
mus graft on C5 - mice . Adult C5-
(BIO.D20SN) hosts were thymecto-
mized, grafted with neonatal thymus
from C5 - or C5' (B10.D2NSN) do-
nors, irradiated, and reconstituted .
Mice were immunizedwith C5/OVA/
CFAfollowed by a booster immuniza-
tion 2 wk later. Anti-C5 antibody was
assayed by inhibition ofC5-dependent
hemolysis (6) . The left panel represents
the primary response (day 14) mea-
sured at a serum dilution of 1 :25 ; the
right panel represents the secondary re-
sponse (day 21) measured at a serum
dilution of 1 :50 . NSN, normal C5'-
immunized controls; OSN, normal
C5 - -immunized controls ; OSN Tx +
OSN Thy, C5- -thymectomized mice
grafted with neonatal C5- thymus,
irradiated and reconstituted as de-
scribed ; OSN Tx + NSN Thy, C5 -
thymectomized mice grafted with neo-
natal C5' thymus, irradiated and re-
constituted as above . Shaded area rep-
resents the mean ± 2 SD of normal
unimmunized C5 - control sera .BOGUNIEWICZ ET AL .
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FIGURE 2 .
￿
(A) Adoptive transfer of toler-
ance by immunized donors . NA spleen
cells from both groups ofimmunize grafted
mice described in Fig . 1 were injected into
irradiated C5- recipients. NA spleen cells
from unimmunizedC5- and C5' donors
into C5 - hosts served as controls . All
groups were immunized with C5/OVA/
CFA on days 0 and 14 and anti-C5 re-
sponse wasmeasured by inhibition of C5-
dependenthemolysis on days 14 and 21 at
serum dilutions of 1 :25 and 1 :50, respec-
tively . OSN + OSN, NA spleen cells from
normal C5- donors into irradiated C5-
hosts ; OSN + NSN, NA spleen cells from
normal C5' donors into irradiated C5-
hosts ; OSN + (OSN Tx* + OSN Thy),
NA spleen cells from thymectomized C5-
mice grafted with C5- neonatal thymus,
irradiated andreconstituted, immunized
with C5/CFA into irradiated C5 - hosts .
OSN + (OSN Tx* + NSN Thy), NA
spleen cells from thymectomized C5 -
mice grafted with C5' neonatal thymus,
irradiated and reconstituted, immunized
with C5/CFA into irradiated C5 - hosts .
(B) Adoptive transfer oftolerance by unim-
munized donors . Control and experie-
mental groups were as in A, except that
NA spleen cells were transferred from
unimmunized mice 3 mo after reconsti-
tution . NSN, normal C5' controls ; OSN
+ NSN, NA spleen cells from normal
C5' donors into irradiated C5- host ;
OSN + OSN, NA spleen cells from
normal C5- donors into irradiated C5 - hosts ; OSN + (OSN Tx + OSN Thy), NA spleen cells from
thymectomizedC5- mice grafted with neonatal C5 - thymus, irradiated and reconstituted into irradi-
ated C5 - hosts ; OSN + (OSN Tx + NSN Thy), NA spleen cells from thymectomized C5 - mice grafted
with neonatal C5' thymus, irradiated and reconstituted into irradiated C5- hosts .
TABLE I
Specificity of Tolerance Induction to C5 in Mice
Immunized with C5 and OVA
Group
￿
Anti-OVA
OD
OSN Tx + OSN Thy
￿
0.866
OSN Tx + NSN Thy
￿
1 .069
OSN + (OSN Tx + OSN Thy)
￿
1 .628
OSN + (OSN Tx + NSN Thy)
￿
1 .785
Anti-OVA antibody response measured by ELISA at sera dilution of 1 :1,000 .
OD of unimmunized C5" and C5` mice was 0 . OD, mean OD o£ individual
mice in each group (six to eight mice/group) - (background + 2 SD). OSN
Tx + OSNThy, thymectomized C5 - mice grafted with C5- neonatal thymus,
irradiated and reconstituted with anti-Thy-1 .2 + C-treated C5- bone marrow
cells . OSN Tx + NSN Thy, thymectomized C5 - mice grafted with C5` ne-
onatal thymus, irradiated and reconstituted with anti-Thy-1 .2 + C-treatedC5-
bone marrow cells . OSN + (OSN Tx + OSN Thy), nonadherent spleen cells
of C5- mice grafted with C5 - neonatal thymus into C5- host . OSN + (OSN
Tx + NSN Thy), nonadherent spleen cells of C5- mice grafted with C5' ne-
onatal thymus into C5 - host .288
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To further establish that tolerance was induced in this system, we determined whether
we could transfer the state of tolerance with lymphoid cells. NA spleen cells from
both groups discussed above were adoptively transferred into irradiated C5 - hosts
(Fig. 2 A). The results show that C5 - hosts that received cells from previously im-
munized C5- donors grafted with autologous thymus responded better than C5-
controls in the 1° response. In contrast, both the C5- hosts receiving NA spleen
cells from immunized C5- mice grafted with C5+ thymus or from C5+ controls
failed to respond both in the primary and secondary response to C5 . Because an-
tigen in CFA has already been shown to maintain tolerance (6), we were concerned
that successful adoptive transfer could be due in part to immunization of the first
host . The experiment was therefore repeated by transferring cells from unimmunized
C5- mice grafted either with C5+ or C5- thymus. The interval between reconsti-
tution of the primary host and adoptive transfer into the secondary host was ex-
tended to 3 mo. Again, serum C5 levels were undetectable in both groups. The results
(Fig. 2 B) confirm the previous findings and clearly show that tolerance was trans-
ferred whether or not the donor was immunized with antigen in CFA. There is a
striking difference in the response of C5 - hosts repopulated with spleen cells of C5-
mice grafted with C5 - as opposed to C5+ neonatal thymus in both the primary and
secondary responses. C5- mice grafted with autologous young thymus responded
better in the 1° response than intact controls.
To establish the specificity of tolerance induction, C5- mice with either C5 - or
C5+ neonatal thymus grafts were immunized after reconstitution with both C5 and
an irrelevant antigen, OVA in CFA . Mice tolerant to C5 responded to OVA as well
as the nontolerant groups as measured by an ELISA (Table I) . Furthermore, both
groups of secondary hosts in the adoptive transfer experiments immunized with both
antigens showed no difference in response to OVA. Thus, tolerance to C5 is antigen
specific.
Discussion
The above results are, as far as we know, the first to demonstrate formally that
tolerance to autologous protein antigen originates in the thymus. This is consistent
with observations showing that the thymus is the site of tolerance induction to both
allo and self MHC 2-5, 7), but inconsistent with the view that tolerance is induced
at a prethymic stage (8, 9). Previous experiments have shown that T cells, but not
B cells, are tolerant to C5 (6). In addition, both helper and suppressor T cells appear
to be involved in the cellular mechanism (10). Since the antigen is required not only
to induce but also to maintain tolerance to C5 (6), it seems paradoxical that un-
responsiveness was induced in C5- mice engrafted with C5+ thymus when the an-
tigen C5 was undetectable in the serum. We have to assume that C5 known to be
present on monocyte cell surfaces (11) was carried over by the thymus graft. Pro-C5
present inside the macrophage of C5- mice (12) is not tolergenic since C5 - mice
make anti-C5 antibody when immunized with C5 (6). Because the MHC of both
C5- and C5 + thymus grafts is the same, the only difference between the two groups
of mice is the presence of the antigen.
Where and how then is tolerance to self antigen induced? Some controversy re-
mains as to the role of epithelial cells of the cortex and the hematopoetic-derived
macrophage/dendritic cells of the medulla and corticomedullary junction in the in-BOGUNIEWICZ ET AL.
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duction of tolerance to alloantigen (2, 13). Our experiments did not distinguish as
to which cells of the thymus graft were involved in the induction of tolerance to au-
tologous soluble protein antigen. Nevertheless, it is reasonable to postulate that toler-
ance to C5 was induced in bone marrow-derived lymphoid cells of the C5 - host
by the presence of antigen on the radioresistant component ofthe C5+ thymus graft.
Since helper T cells are required to make anti-C5 antibody (6), how are they ren-
dered tolerant? Three cellular mechanisms should be considered: (a) clonal dele-
tion, (b) immunoregulation by suppressor T cells; and (c) direct inactivation of the
T célls by the antigen. Clonal deletion has been formally demonstrated for self MHC
(5). Recently, this observation has been extended by two groups to non-MHC an-
tigen (14, 15). There are also data consistent with clonal deletion as the mechanism
for tolerance to class I alloantigens on cell surfaces (7). Whether clonal deletion is
also applicable to autologous soluble protein antigen presented by class II MHC
molecules is unknown. It is widely held that to induce T cell tolerance, antigen bound
to self MHC must interact with a TCR . What is remarkable in the above model
is that not only are the MHC loci of the C5 - and C5+ mice identical, but also that
the TCR for C5 is presumably the same. Since it is now established that there is
a single TCR for both antigen and self MHC, our results could support the hypoth-
esis that antigen presentation by identical MHC to the same TCR is not necessarily
different for induction of tolerance and immunity. Thus, it is unlikely that a hole
in the T cell repertoire can explain tolerance to C5. C5+ mice contain suppressor
T cells that prevent production of humoral antibody to C5 (10) and the possibility
that helper T cells are down-regulated by suppressor T cells must be considered.
Since natural tolerance is so profound and longlasting, the latter could be only one
fail safe mechanism to protect the host against autoimmunity. This phenomenon
is therefore more likely explained by functional T cell inactivation by tolerogen without
physical deletion as shown for both lysozyme (16) and cytochrome c (17). Further
experiments with the C5 model will help to distinguish between T cell inactivation
and deletion.
Finally, the finding that natural tolerance originates in the thymus may have clin-
ical implications since thymectomy is known to result in autoimmune phenomena
(18-20). If indeed a healthy thymus plays a role in protecting the host against devel-
opment of autoimmune disease, transplantation ofthymic tissue might be of benefit
in its treatment.
Summary
C5-deficient mice grafted with thymus from C5-sufficient donors and immunized
with C5 failed to make humoral antibody to C5, suggesting that the transfer ofthymus
had induced tolerance. Irradiated C5-deficient hosts repopulated with lymphoid cells
from thymectomized C5-deficient mice grafted with C5-sufficient thymus also failed
to respond to immunization with C5, thus showing that the state of tolerance can
be adoptively transferred. These results demonstrate that natural tolerance to self-
protein antigen is "learned" in the thymus.
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